文献速递头颈部肿瘤放疗放疗物理与技术

头颈部自适应放疗中重新计划的最佳时机

Optimal timing of re-planning for head and neck adaptive radiotherapy.
PubMed 文献 · Radiother Oncol · 2024-02-08

该回顾性研究纳入110例头颈部癌症患者,采用半自动分割法获取危及器官每周平均剂量,通过剂量偏差图模拟1至6次重新计划的自适应放疗方案。结果显示第3周是10个危及器官重新计划的最佳时机建议,除杓状软骨外2次重新计划可使累积平均剂量偏差低于3 Gy,2_4、3_4、3_5周方案可使99%患者19个危及器官的偏差同时低于3 Gy。

要点

  • 第3周被建议为10个危及器官重新计划的最佳时机。
  • 除杓状软骨外,2次重新计划可使累积平均剂量偏差低于3 Gy且平均绝对偏差低于1 Gy。
  • 2_4、3_4、3_5周方案可使99%患者19个危及器官的累积平均剂量偏差同时低于3 Gy。

核心结论

  • 研究为头颈部自适应放疗中不同危及器官提出了重新计划的最佳时机建议,通用时机与频率方案可保证多个器官累积平均剂量增加同时控制在3 Gy以内。

研究设计与样本

  • 回顾性纳入110例头颈部癌症患者,采用半自动分割方法获取危及器官每周平均剂量,用K近邻法插补缺失的每周平均剂量数据。
  • 利用计划平均剂量与每周平均剂量构建剂量偏差图,模拟包含1至6次重新计划的不同自适应放疗场景,比较重新计划前(ΔDmean_acc_noART)与重新计划后(ΔDmean_acc_ART)累积平均剂量与计划平均剂量的差异。

主要发现

  • 在所有危及器官中,声门上区ΔDmean_acc_noART最大,为1.23 ± 3.13 Gy,且ΔDmean_acc_noART > 3 Gy的病例最多(26例患者)。
  • 第3周被建议为10个危及器官重新计划的最佳时机。
  • 除杓状软骨外,所有器官2次重新计划即可保证ΔDmean_acc_ART低于3 Gy,同时平均|ΔDmean_acc_ART|低于1 Gy。
  • 2_4、3_4、3_5(重新计划周次以「_」分隔)方案可使99%患者的19个危及器官ΔDmean_acc_ART同时低于3 Gy。

关键数值与推荐

  • 声门上区ΔDmean_acc_noART为1.23 ± 3.13 Gy,ΔDmean_acc_noART > 3 Gy者26例患者。
  • 第3周被建议为10个危及器官重新计划的最佳时机。
  • 除杓状软骨外,2次重新计划可使ΔDmean_acc_ART低于3 Gy且平均|ΔDmean_acc_ART|低于1 Gy。
  • 2_4、3_4、3_5周方案可使99%患者19个危及器官的ΔDmean_acc_ART同时低于3 Gy。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Adaptive radiotherapy (ART) relies on re-planning to correct treatment variations, but the optimal timing of re-planning to account for dose changes in head and neck organs at risk (OARs) is still under investigation. We aimed to find out the optimal timing of re-planning in head and neck ART. MATERIALS AND METHODS: A total of 110 head and neck cancer patients were retrospectively enrolled. A semi auto-segmentation method was applied to obtain the weekly mean dose (Dmean) to OARs. The K-nearest-neighbour method was used for missing data imputation of weekly Dmean. A dose deviation map was built using the planning Dmean and weekly Dmean values and then used to simulate different ART scenarios consisting of 1 to 6 re-plannings. The difference between accumulated Dmean and planning Dmean before re-planning (ΔDmean_acc_noART) and after re-planning (ΔDmean_acc_ART) were evaluated and compared. RESULTS: Among all the OARs, supraglottic showed the largest ΔDmean_acc_noART (1.23 ± 3.13 Gy) and most cases of ΔDmean_acc_noART > 3 Gy (26 patients). The 3rd week is suggested in the optimal timing of re-planning for 10 OARs. For all the organs except arytenoid, 2 re-plannings were able to guarantee the ΔDmean_acc_ART below 3 Gy while the average |ΔDmean_acc_ART| was below 1 Gy. ART scenarios of 2_4, 3_4, 3_5 (week of re-planning separated with "_") were able to guarantee ΔDmean_acc_ART of 99 % of patients below 3 Gy simultaneously for 19 OARs. CONCLUSIONS: The optimal timing of re-planning was suggested for different organs at risk in head and neck adaptive radiotherapy. Generic scenarios of timing and frequency for re-planning can be applied to guarantee the increase of accumulated mean dose within 3 Gy simultaneously for multiple organs.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Gan Y, Langendijk JA, Oldehinkel E, et al. Optimal timing of re-planning for head and neck adaptive radiotherapy. Radiother Oncol. 2024. PMID: 38341093. doi:10.1016/j.radonc.2024.110145

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。